[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eupraxia Pharmaceuticals Inc (EPRX.TO)

Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 586,636
  • Shares Outstanding, K 65,327
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,576 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.10 +10.86%
on 07/24/26
10.05 -10.65%
on 07/09/26
-0.33 (-3.54%)
since 06/30/26
3-Month
7.85 +14.39%
on 06/16/26
11.04 -18.66%
on 05/01/26
-1.67 (-15.68%)
since 04/30/26
52-Week
6.94 +29.39%
on 08/26/25
12.86 -30.17%
on 01/21/26
+1.77 (+24.55%)
since 07/30/25

Most Recent Stories

More News
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI Completion of a $63.2 million public offering to enable clinical trials of EP-104GI in additional indications...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Stocks in play: Eupraxia Pharmaceuticals Inc.

Announced the first release of sub score data from the Eosinophilic Esophagitis Histologic Scoring System ...

EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

EoEHSS (EoE Histology Scoring System) is a standardized method used to monitor esophageal tissue damage in EoE patients. Sub scores of EoEHSS are reported to specifically evaluate the tissue inflammation...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)

EREFS is a standardized visual scoring system that gastroenterologists use when performing an endoscopy in EoE patients to assess the severity of inflammation and fibrosis in the esophagus EREFS...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its...

EPRX : 6.51 (+1.72%)
EPRX.TO : 8.98 (-1.32%)
Stocks in play: Eupraxia Pharmaceuticals Inc.

Announced that the Company will present 4 abstracts at Digestive Disease Week Annual meeting being held ...

EPRX.TO : 8.98 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages...

See More

Key Turning Points

3rd Resistance Point 10.02
2nd Resistance Point 9.70
1st Resistance Point 9.34
Last Price 8.98
1st Support Level 8.66
2nd Support Level 8.34
3rd Support Level 7.98

See More

52-Week High 12.86
Fibonacci 61.8% 10.60
Fibonacci 50% 9.90
Fibonacci 38.2% 9.20
Last Price 8.98
52-Week Low 6.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.